Cholesterol Efflux Capacity and Anti-Oxidative Activity of High-Density Lipoprotein in Chronic Kidney Disease

Hiroyuki Suzuki1,2, Masatsune Ogura3,4, Hiroko Kakita1

  • 1Department of Nephrology and Dialysis, Medical Research Institute Kitano Hospital, PIIF Tazuke-Kofukai.

Insights

In chronic kidney disease (CKD) patients, high-density lipoprotein cholesterol (HDL-C) levels do not reflect HDL functionality. Impaired HDL function is linked to reduced kidney function and increased urinary protein levels.

Area of Science:

  • Nephrology
  • Cardiovascular Research
  • Biochemistry

Background:

  • Chronic kidney disease (CKD) is associated with altered lipid metabolism and impaired cardiovascular health.
  • Cholesterol efflux capacity (CEC) and anti-oxidative activity are key indicators of high-density lipoprotein (HDL) functionality.
  • Understanding these functionalities in CKD is crucial for managing associated risks.

Purpose of the Study:

  • To investigate the alterations in cholesterol efflux capacity (CEC) and anti-oxidative activity (oxygen radical adsorption capacity, ORAC) in patients with chronic kidney disease (CKD).
  • To identify clinical and kidney injury parameters related to these functional changes in CKD patients.

Main Methods:

  • A retrospective cross-sectional observational study involving 333 CKD patients who underwent kidney biopsy.
  • Serum samples collected during biopsy were analyzed for CEC and ORAC.
  • Clinical data, including body mass index (BMI), high-density lipoprotein-cholesterol (HDL-C), serum albumin, urinary protein creatinine ratio (UPCR), and estimated glomerular filtration rate (eGFR), were evaluated.

Main Results:

  • Mean CEC and ORAC were 0.83±0.15 and 0.86±0.14, respectively.
  • HDL-C levels were significantly associated with both CEC and ORAC, but CEC showed only a weak association with ORAC.
  • CEC and HDL-C were negatively correlated with BMI and higher in women. ORAC positively correlated with serum albumin and negatively with UPCR.
  • Multiple regression analysis indicated CEC is associated with eGFR, serum albumin, and ORAC. No correlation was found between global sclerosis and CEC or ORAC.

Conclusions:

  • Serum HDL-C levels are not a reliable indicator of HDL functionality in CKD patients.
  • Decreased eGFR and reduced serum albumin, potentially due to increased UPCR, are associated with impaired HDL functionalities in CKD.
  • These findings highlight the complex interplay between kidney function, lipid metabolism, and oxidative stress in CKD progression.
Abstract

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
65
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
77
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
85
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
669
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
865
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
154